PE20040757A1 - Derivados de benzoxazina - Google Patents
Derivados de benzoxazinaInfo
- Publication number
- PE20040757A1 PE20040757A1 PE2003000452A PE2003000452A PE20040757A1 PE 20040757 A1 PE20040757 A1 PE 20040757A1 PE 2003000452 A PE2003000452 A PE 2003000452A PE 2003000452 A PE2003000452 A PE 2003000452A PE 20040757 A1 PE20040757 A1 PE 20040757A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- benzo
- piperazin
- chloro
- oxazine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA I DONDE m ES DE 0 A 3; n Y p SON CADA UNO DE 2 A 3; Y ES -S(O2)-, -S(O2)-N(R10)-; R10 ES H O ALQUILO INFERIOR; Z1 ES CH, N; R1 Y R2 SON CADA UNO H O ALQUILO; R3 ES ALQUILO, ARILO, HALOALQUILO, ENTRE OTROS; LOS R4 SON CADA UNO HALO, ALQUILO, HALOALQUILO, CIANO, ENTRE OTROS; R5, R6, R7 Y R8 SON CADA UNO H O ALQUILO; R9 ES H, ALQUILO, CICLOALQUILO, BENCILO, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: 6-CLORO-4-(4-METANOSULFONIL-BENCENOSULFONIL)-8-PIPERAZIN-1-IL-3,4-DIHIDRO-2H-BENZO[1,4]OXAZINA; 6-CLORO-4-(3-FLUORO-BENCENOSULFONIL)-8-PIPERAZIN-1-IL-3,4-DIHIDRO-2H-BENZO[1,4]OXAZINA Y 4-(BENZO[1,2,5] TIADIAZOL-4-SULFONIL)-6-CLORO-8-PIPERAZIN-1-IL-3,4-DIHIDRO-2H-BENZO[1,4]OXAZINA; ENTRE OTROS. SE REFIERE TAMBIEN A COMPOSICIONES ASOCIADAS. DICHOS COMPUESTOS SON AGONISTAS 5HT6 UTILES EN EL TRATAMIENTO DE CIERTOS TRASTORNOS DEL SNC
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37800302P | 2002-05-13 | 2002-05-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20040757A1 true PE20040757A1 (es) | 2004-11-06 |
Family
ID=29420358
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2003000452A PE20040757A1 (es) | 2002-05-13 | 2003-05-09 | Derivados de benzoxazina |
Country Status (37)
| Country | Link |
|---|---|
| US (4) | US6867204B2 (es) |
| EP (1) | EP1506179B1 (es) |
| JP (1) | JP4307377B2 (es) |
| KR (1) | KR100636475B1 (es) |
| CN (1) | CN100429206C (es) |
| AR (1) | AR039988A1 (es) |
| AT (1) | ATE316523T1 (es) |
| AU (1) | AU2003233231B2 (es) |
| BR (1) | BRPI0310032B8 (es) |
| CA (1) | CA2485136C (es) |
| DE (1) | DE60303376T2 (es) |
| DK (1) | DK1506179T3 (es) |
| EA (1) | EA009982B1 (es) |
| EC (1) | ECSP045420A (es) |
| EG (1) | EG25683A (es) |
| ES (1) | ES2256744T3 (es) |
| GT (1) | GT200300108A (es) |
| HK (1) | HK1080846A1 (es) |
| HR (1) | HRP20041030B1 (es) |
| IL (1) | IL164928A0 (es) |
| JO (1) | JO2413B1 (es) |
| MA (1) | MA27118A1 (es) |
| MX (1) | MXPA04011254A (es) |
| MY (1) | MY139612A (es) |
| NO (1) | NO329380B1 (es) |
| NZ (1) | NZ536230A (es) |
| PA (1) | PA8573501A1 (es) |
| PE (1) | PE20040757A1 (es) |
| PL (1) | PL211057B1 (es) |
| PT (1) | PT1506179E (es) |
| RS (1) | RS51042B (es) |
| TN (1) | TNSN04225A1 (es) |
| TW (1) | TWI258479B (es) |
| UA (1) | UA76877C2 (es) |
| UY (1) | UY27803A1 (es) |
| WO (1) | WO2003095434A1 (es) |
| ZA (1) | ZA200408783B (es) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003007956A1 (en) | 2001-07-20 | 2003-01-30 | Psychogenics, Inc. | Treatment for attention-deficit hyperactivity disorder |
| NZ535239A (en) | 2002-03-27 | 2008-03-28 | Glaxo Group Ltd | Quinoline derivatives and their use as 5-HT6 ligands |
| WO2003095434A1 (en) * | 2002-05-13 | 2003-11-20 | F. Hoffmann-La Roche Ag | Benzoxazine derivatives as 5-ht6 modulators and uses thereof |
| EP1562918B1 (en) | 2002-11-08 | 2008-01-16 | F. Hoffmann-La Roche Ag | Substituted benzoxazinones and uses thereof |
| MY141862A (en) | 2003-07-22 | 2010-07-16 | Arena Pharm Inc | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto |
| RU2354651C2 (ru) | 2003-12-09 | 2009-05-10 | Ф.Хоффманн-Ля Рош Аг | Производные бензоксазина и их применение |
| DE602005005298T2 (de) * | 2004-01-16 | 2009-03-12 | F. Hoffmann-La Roche Ag | 1-benzyl-5-piperazin-1-yl-3,4 dihydro-1h-chinazolin-2-on-derivate und die jeweiligen 1h-benzo(1,2,6)thiadiazin-2,2-dioxid und 1,4-dihydro-benzo(d)(1,3)oxazin-2-on-derivate als modulatoren des 5-hydroxytryptamin-rezeptors (5-ht) zur behandlung von erkrankungen des zentralen nervensystems |
| NZ550441A (en) * | 2004-05-05 | 2009-07-31 | Hoffmann La Roche | Arylsulfonyl benzodioxanes useful for modulating the 5-HT6 receptor, the 5-HT2A receptor or both |
| BRPI0516749B8 (pt) * | 2004-09-30 | 2021-05-25 | Hoffmann La Roche | composições compreendendo antagonistas dos receptores 5-ht2a e 5-ht6 e uso destes para o tratamento de distúrbios cognitivos |
| US7713954B2 (en) * | 2004-09-30 | 2010-05-11 | Roche Palo Alto Llc | Compositions and methods for treating cognitive disorders |
| RU2382036C2 (ru) * | 2004-09-30 | 2010-02-20 | Ф.Хоффманн-Ля Рош Аг | Производные бензоксазина и хиноксалина и их применение |
| US7378415B2 (en) * | 2004-09-30 | 2008-05-27 | Roche Palo Alto Llc | Benzoxazine and quinoxaline derivatives and uses thereof |
| EP2254564A1 (en) | 2007-12-12 | 2010-12-01 | Glaxo Group Limited | Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline |
| WO2009123714A2 (en) | 2008-04-02 | 2009-10-08 | Arena Pharmaceuticals, Inc. | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
| WO2010062321A1 (en) | 2008-10-28 | 2010-06-03 | Arena Pharmaceuticals, Inc. | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto |
| AR078770A1 (es) * | 2009-10-27 | 2011-11-30 | Elara Pharmaceuticals Gmbh | Derivados de dihidrobenzo oxacinas y tiazinas, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades inflamatorias e hiperproliferativas. |
| KR101293384B1 (ko) * | 2010-10-13 | 2013-08-05 | 주식회사 대웅제약 | 신규 피리딜 벤조옥사진 유도체, 이를 포함하는 약학 조성물 및 이의 용도 |
| US9403800B2 (en) * | 2012-01-24 | 2016-08-02 | Chemregen, Inc. | Compounds for inhibition of cancer cell proliferation |
| EP3091984B1 (en) * | 2014-01-09 | 2020-04-22 | The J. David Gladstone Institutes, A Testamentary Trust Established under The Will of J. David Gladstone | Substituted benzoxazine and related compounds |
| US10022355B2 (en) | 2015-06-12 | 2018-07-17 | Axovant Sciences Gmbh | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of REM sleep behavior disorder |
| BR112018000728A2 (pt) | 2015-07-15 | 2018-09-04 | Axovant Sciences Gmbh | resumo método para a profilaxia e/ou tratamento de alucinações visuais em um sujeito com necessidade do mesmo |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1029479C (zh) * | 1989-11-08 | 1995-08-09 | 山之内制药株式会社 | 新型苯并噁嗪衍生物的制备方法 |
| US5492914A (en) * | 1994-07-28 | 1996-02-20 | Syntex (U.S.A.) Inc. | 2-(1-azabicyclo[2.2.2]oct-3 s-yl)-6-hydroxy-2,4,5,6-tetrahydro-1H-benz[DE]is[2.2.2]oct-3's-yl)-6-hydroxy-2,3,3a,4,5,6-hexahydro-1h-benz [DE]isoquinolin-1-one and individual stereoisomers thereof |
| GB9507203D0 (en) | 1995-04-07 | 1995-05-31 | Smithkline Beecham Plc | Novel compounds |
| DZ2376A1 (fr) * | 1996-12-19 | 2002-12-28 | Smithkline Beecham Plc | Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant. |
| CN1260781A (zh) | 1997-04-18 | 2000-07-19 | 史密丝克莱恩比彻姆有限公司 | 具有综合的5ht1a、5ht1b和5ht1d受体拮抗剂活性的吲哚衍生物 |
| CN1087294C (zh) | 1997-07-11 | 2002-07-10 | 史密丝克莱恩比彻姆有限公司 | 新化合物 |
| DE69819173T2 (de) * | 1997-07-25 | 2004-04-15 | H. Lundbeck A/S | Indole und 2,3-dihydroindolderivate, ihre herstellung und verwendung |
| GB9801392D0 (en) | 1998-01-22 | 1998-03-18 | Smithkline Beecham Plc | Novel compounds |
| HUP0101475A3 (en) * | 1998-06-19 | 2003-01-28 | Lundbeck & Co As H | 4,5,6 and 7-indole and indoline derivatives, their preparation and use |
| GB9818916D0 (en) * | 1998-08-28 | 1998-10-21 | Smithkline Beecham Plc | Use |
| US6380235B1 (en) | 1999-05-04 | 2002-04-30 | American Home Products Corporation | Benzimidazolones and analogues |
| NZ517900A (en) * | 1999-08-23 | 2003-08-29 | Solvay Pharm Bv | Phenylpiperazines useful as serotonin reuptake inhibitors |
| US6566372B1 (en) | 1999-08-27 | 2003-05-20 | Ligand Pharmaceuticals Incorporated | Bicyclic androgen and progesterone receptor modulator compounds and methods |
| US20020013314A1 (en) | 2000-02-01 | 2002-01-31 | Bing-Yan Zhu | 3,4-dihydro-2H-benzo[1,4]oxazine inhibitors of factor Xa |
| WO2003095434A1 (en) * | 2002-05-13 | 2003-11-20 | F. Hoffmann-La Roche Ag | Benzoxazine derivatives as 5-ht6 modulators and uses thereof |
-
2003
- 2003-05-05 WO PCT/EP2003/004671 patent/WO2003095434A1/en active IP Right Grant
- 2003-05-05 NZ NZ536230A patent/NZ536230A/en not_active IP Right Cessation
- 2003-05-05 AT AT03727430T patent/ATE316523T1/de active
- 2003-05-05 KR KR1020047018299A patent/KR100636475B1/ko active IP Right Grant
- 2003-05-05 MX MXPA04011254A patent/MXPA04011254A/es active IP Right Grant
- 2003-05-05 DK DK03727430T patent/DK1506179T3/da active
- 2003-05-05 CN CNB038109972A patent/CN100429206C/zh not_active Expired - Lifetime
- 2003-05-05 EA EA200401455A patent/EA009982B1/ru not_active IP Right Cessation
- 2003-05-05 EP EP03727430A patent/EP1506179B1/en not_active Expired - Lifetime
- 2003-05-05 RS YUP-970/04A patent/RS51042B/sr unknown
- 2003-05-05 PT PT03727430T patent/PT1506179E/pt unknown
- 2003-05-05 JP JP2004503451A patent/JP4307377B2/ja not_active Expired - Lifetime
- 2003-05-05 DE DE60303376T patent/DE60303376T2/de not_active Expired - Lifetime
- 2003-05-05 AU AU2003233231A patent/AU2003233231B2/en not_active Expired
- 2003-05-05 CA CA2485136A patent/CA2485136C/en not_active Expired - Lifetime
- 2003-05-05 PL PL374019A patent/PL211057B1/pl unknown
- 2003-05-05 UA UA20041210144A patent/UA76877C2/uk unknown
- 2003-05-05 BR BRPI0310032A patent/BRPI0310032B8/pt not_active IP Right Cessation
- 2003-05-05 ES ES03727430T patent/ES2256744T3/es not_active Expired - Lifetime
- 2003-05-08 TW TW092112575A patent/TWI258479B/zh not_active IP Right Cessation
- 2003-05-08 JO JO200352A patent/JO2413B1/en active
- 2003-05-09 US US10/435,732 patent/US6867204B2/en not_active Expired - Lifetime
- 2003-05-09 AR ARP030101624A patent/AR039988A1/es active IP Right Grant
- 2003-05-09 GT GT200300108A patent/GT200300108A/es unknown
- 2003-05-09 PE PE2003000452A patent/PE20040757A1/es active IP Right Grant
- 2003-05-09 PA PA20038573501A patent/PA8573501A1/es unknown
- 2003-05-10 EG EG2003050432A patent/EG25683A/xx active
- 2003-05-12 UY UY27803A patent/UY27803A1/es not_active IP Right Cessation
- 2003-05-12 MY MYPI20031765A patent/MY139612A/en unknown
-
2004
- 2004-10-28 IL IL16492804A patent/IL164928A0/xx unknown
- 2004-10-28 NO NO20044665A patent/NO329380B1/no not_active IP Right Cessation
- 2004-10-29 ZA ZA2004/08783A patent/ZA200408783B/en unknown
- 2004-11-03 HR HRP20041030AA patent/HRP20041030B1/hr not_active IP Right Cessation
- 2004-11-10 EC EC2004005420A patent/ECSP045420A/es unknown
- 2004-11-11 TN TNP2004000225A patent/TNSN04225A1/fr unknown
- 2004-11-12 MA MA27944A patent/MA27118A1/fr unknown
-
2005
- 2005-01-31 US US11/047,284 patent/US20050130962A1/en not_active Abandoned
-
2006
- 2006-01-18 HK HK06100802.2A patent/HK1080846A1/xx not_active IP Right Cessation
-
2009
- 2009-09-04 US US12/584,373 patent/US8377931B2/en active Active
-
2012
- 2012-12-13 US US13/713,484 patent/US20130123251A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20040757A1 (es) | Derivados de benzoxazina | |
| PE20050132A1 (es) | Piperazinas heterociclicas sustituidas | |
| PE20050676A1 (es) | Quinolinas referidas a enfermedades cardiovasculares | |
| PE20040512A1 (es) | Compuesto de pirazol-pirimidina anilina | |
| PE20060483A1 (es) | Compuestos heterociclicos como antagonistas de nk1 | |
| NO20052469L (no) | Inhibitorer av II-beta-hydroksysteroid-dehydrogenase type 1 og type 2. | |
| PE20001467A1 (es) | Derivados de 4-fenilpiridina como antagonistas del receptor de neuroquinina | |
| PE20040772A1 (es) | Composicion y actividad antiviral de derivados de piperazina azaindoloxoaceticos | |
| PE20020657A1 (es) | Derivados de amida de piperidinas 1,4-disustituidas de formula (i) | |
| PE106499A1 (es) | Antagonistas del receptor ccr-3 | |
| CO5590957A2 (es) | Amino-1,3,5-triazinas sustituidas en n con radicales biciclicos quirales, procedimiento para su preparacion, composiciones de las mismas y su uso como herbicidas y reguladores del crecimiento de las plantas | |
| CO5690643A2 (es) | Derivados de triaza-espiropiperidina para usarlos como inhibidores de glyt-1 en el tratamiento de desordenes neurologicos y neuropsiquiatricos | |
| PE20060875A1 (es) | Derivados de triazol sustituidos como antagonistas de oxitocina | |
| AR035892A1 (es) | Derivados de oxazol, proceso para su preparacion, composiciones farmaceuticas que los comprenden, y el uso de dichos compuestos en la preparacion de medicamentos | |
| AR055360A1 (es) | Inhibidores macrociclicos del virus de la hepatitis c | |
| AR055878A1 (es) | Derivados de ciclopropanocarboxamida | |
| ECSP034720A (es) | Derivado de isoxazolina y herbicida que lo contiene como ingrediente activo | |
| PE20030440A1 (es) | Fenilsulfonamidas como antagonistas de ccr3 | |
| PE20090601A1 (es) | Derivados de piridin-il-oxi-piridinas como inhibidores de alk5 | |
| AR037907A1 (es) | Derivados de azaindolilalquilamina como ligandos de 5-hidroxitriptamina-6 | |
| PE20030610A1 (es) | Derivados de 3-azabiciclo[3.1.0]hexano con afinidad a los receptores opioides | |
| PE20030653A1 (es) | COMPUESTOS BICICLICOS[1,2,4]-TRIAZOL COMO ANTAGONISTAS DE RECEPTORES DE ADENOSINA A2a | |
| PE20041078A1 (es) | Derivados heterociclicos inhibidores de la elastasa leucocitica humana (elh) | |
| PE20030761A1 (es) | Derivados del 7-amino-benzotiazol | |
| PE20050226A1 (es) | Productos aril-heteroaromaticos y composiciones que los contienen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |